News Archives - Page 503 of 735

ThursdayOct 08, 2020 12:03 pm

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Positioned to Benefit from Gold’s Steady Rise

Citi experts predict gold could reach $2,100 an ounce this quarter, $2,300 in the next 6 to 12 months Precious metal’s consistent performance has resulted in investors looking to reduce risks, maintain purchasing power by buying more gold GOH recently entered into agreements to acquire seven advanced gold projects in the Maricunga Gold Belt of Chile In a detailed explanation of why gold will likely continue its upward trend for at least the foreseeable future, Citi economists conclude that “you would expect gold to perform extremely well” (https://ibn.fm/ZY4Q2). That upward trajectory stands to benefit a wide variety of companies operating in…

WednesdayOct 07, 2020 12:13 pm

Kaival Brands Innovations Group Inc. (KAVL) Benefits from Vaping Industry’s Explosive Growth

Kaival Brands’ flagship product, vaping device Bidi(TM) Stick, has rapidly taken dominant position in e-cigarette market E-cigarette segment set to grow to market size of $59.3 billion by 2027, CAGR of 19.6% over next seven years The Bidi(TM) Stick now available across thousands of retailers in United States, as far afield as Guam Kaival Brands recently reported blowout earnings, with quarterly sales surpassing $32 million Kaival Brands Innovations Group (OTCQB: KAVL), which focuses on growing and incubating innovative and profitable products into mature, dominant brands, is the sole distributor of the Bidi(TM) Stick, an innovative completely-contained disposable nicotine vaping device…

WednesdayOct 07, 2020 11:43 am

Pac Roots Cannabis Corp. (CSE: PACR) Committed to Superior Genetics, Quality of Product

PACR has strategic licensing agreement with Phenome One, which owns Canada's largest live genetic cannabis library The company’s optimized farming system distinguishes it from other cannabis operations Pac Roots Cannabis Corp.’s commitment to superior genetics involves careful selection of cultivation sites With its slogan proclaiming “the Future of Genetics,” Canadian cannabis company Pac Roots Cannabis (CSE: PACR) clearly places a top priority on producing premium-quality cannabis strains and products. In fact, while some companies may strive to be the largest cannabis grower, Pac Roots Cannabis Corp. maintains that the quality of the product is paramount. Pac Roots Cannabis Corp. achieves…

TuesdayOct 06, 2020 2:24 pm

The Movie Studio Inc. (MVES) Leveraging Social Media Branding and Influencer Engagement to Promote New App

MVES engaged services of Digital Talent Studio Inc., social media mogul Brian Breach of Sikey Corp. to promote The Movie Studio App The Movie Studio App leverages both advertiser-based and subscription models Social media models, influencers expected to promote app to hundreds of thousands of followers MVES’s two key verticals include open architecture for original content plus an over-the-top platform that pulls additional content through revenue sharing agreements In a bold move to boost the promotion of The Movie Studio App, The Movie Studio Inc. (OTC: MVES), a vertically integrated motion picture production and distribution company, has engaged Digital Talent…

TuesdayOct 06, 2020 2:02 pm

Net Element Inc. (NASDAQ: NETE), Mullen Technologies Announce Facility Build-Out, Pre-Sales of Fully Electric EV

Mullen Technologies begins built-out of pilot facility, accepting orders for MX-05 SUV. Facility slated for April 2021 completion; first MX-05 SUVs rolling off production line by Q2 2022. In August, Net Element, Mullen Technologies announced execution of definitive agreement to merge. The announcement by Mullen Technologies Inc. that it has begun to build out its pilot manufacturing facility and take pre-orders for its M05 fully electric SUV bodes well for Net Element (NASDAQ: NETE). Earlier this year, Net Element, a global financial technology and value-added solutions group, and Mullen Technologies announced a merger agreement—so good news for Mullen means good…

TuesdayOct 06, 2020 12:51 pm

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) is “One to Watch”

Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete Processa’s current development pipeline features multiple clinical drug candidates, given the recent acquisitions of three additional development-focused licensing agreement since June 2020 In total, the company’s combined scientific, development and regulatory experience has resulted in more than 30 drug approvals by the U.S. Food and…

MondayOct 05, 2020 1:44 pm

InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: IGSTF) Partners with Hub International to Expand Hospitality Liability Coverage

The partnership will help InsuraGuest’s coverage potentially reach more than 9,300 hospitality customers in the United States and Canada by the middle of 2021 Hospitality Liability coverage allows covered properties to transfer certain liabilities, lowering claim ratio and risk profiles InsuraGuest’s product can also help properties generate revenue by keeping a percent of the nightly software fee Innovative insurtech leader InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF) has sealed a premier preferred partnership with leading global insurance brokerage Hub International Limited (“HUB”), to provide InsuraGuest’s Hospitality Liability coverage to properties in Hub International’s portfolio. Signed via wholly owned subsidiary InsuraGuest, the…

MondayOct 05, 2020 12:51 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials

Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of Berubicin later this year or in Q1 of 2021, building on promising results shown in initial trials One patient in the Phase I trial has remained cancer-free over the course of 14 years, and 44 percent of the patients who could be evaluated experienced a clinically significant positive response to Berubicin CNS’s laser-focused strategy for developing a GBM therapy is also leading the company to…

MondayOct 05, 2020 12:27 pm

Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy

Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment products The company’s core mission has been to help small, community-centered retail pharmacies compete with large national chains through prescription drug price transparency and AI-driven protocols that help pharmacies stay abreast of what’s available Trxade Group’s advances in delivering services ranging from consultation to drug…

Site Search

Company Search

Category: News